| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP13A4 SCN11A AQP10 SLC2A9 SLC5A9 AQP9 SLC4A1 SLC39A12 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 NIPA2 SLC45A1 | 8.29e-06 | 758 | 157 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 1.61e-05 | 102 | 157 | 7 | GO:0005249 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP13A4 SCN11A AQP10 ABCA1 SLC2A9 SLC5A9 AQP9 SLC4A1 GJA4 SLC39A12 SIDT2 KCNA1 KCNA5 KCNA6 KCNA10 NALCN SLC22A13 KCNJ13 PKD1 KCNK3 KCNMA1 NIPA2 SLC45A1 SVOP | 1.71e-05 | 1180 | 157 | 24 | GO:0022857 |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 1.90e-05 | 42 | 157 | 5 | GO:0015144 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ATP13A4 SCN11A SLC5A9 SLC39A12 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 NIPA2 | 1.91e-05 | 465 | 157 | 14 | GO:0046873 |
| GeneOntologyMolecularFunction | transporter activity | ATP13A4 SCN11A AQP10 ABCA1 SLC2A9 SLC5A9 AQP9 SLC4A1 GJA4 SLC39A12 SIDT2 KCNA1 KCNA5 KCNA6 KCNA10 NALCN SLC22A13 KCNJ13 NPC1L1 PKD1 KCNK3 KCNMA1 NIPA2 SLC45A1 SVOP | 2.49e-05 | 1289 | 157 | 25 | GO:0005215 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP13A4 SCN11A SLC2A9 SLC5A9 SLC39A12 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 NIPA2 SLC45A1 | 3.62e-05 | 627 | 157 | 16 | GO:0022890 |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 6.50e-05 | 28 | 157 | 4 | GO:0005251 | |
| GeneOntologyMolecularFunction | potassium channel activity | 6.93e-05 | 128 | 157 | 7 | GO:0005267 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP13A4 SCN11A SLC2A9 SLC5A9 SLC39A12 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 NIPA2 SLC45A1 | 7.13e-05 | 664 | 157 | 16 | GO:0008324 |
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 1.09e-04 | 60 | 157 | 5 | GO:0005544 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP13A4 SCN11A SLC2A9 SLC5A9 SLC4A1 SLC39A12 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 NIPA2 SLC45A1 | 1.73e-04 | 793 | 157 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | syntaxin-3 binding | 1.83e-04 | 3 | 157 | 2 | GO:0030348 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity, coupled via Gi/Go | 1.83e-04 | 3 | 157 | 2 | GO:0001591 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.03e-04 | 152 | 157 | 7 | GO:0022843 | |
| GeneOntologyMolecularFunction | channel activity | SCN11A AQP10 AQP9 GJA4 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 | 2.68e-04 | 525 | 157 | 13 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SCN11A AQP10 AQP9 GJA4 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 | 2.73e-04 | 526 | 157 | 13 | GO:0022803 |
| GeneOntologyMolecularFunction | phosphatidylserine binding | 2.75e-04 | 73 | 157 | 5 | GO:0001786 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 2.99e-04 | 17 | 157 | 3 | GO:0005402 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.43e-04 | 118 | 157 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 3.60e-04 | 167 | 157 | 7 | GO:0015079 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | SCN11A KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 | 3.95e-04 | 343 | 157 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 6.02e-04 | 182 | 157 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity | 6.05e-04 | 5 | 157 | 2 | GO:0004952 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 6.42e-04 | 184 | 157 | 7 | GO:0022832 | |
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 PCDHGA10 ANXA7 PCDHAC2 HRNR CDH19 TENM2 CDH22 SYT8 SYT1 SYT4 SYT5 EGFLAM LTBP1 ADGRL3 | 8.52e-04 | 749 | 157 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GPBAR1 ABCA1 DRD2 DRD3 PDGFRL OR4D9 OPN1LW SEMA5A OR5M11 OR2T34 OR2T11 IL22RA1 OR6N1 OR2T3 OR2B11 PTPRK GPR158 LPAR6 PKD1 LTBP1 ADGRL3 PLXNB1 | 9.25e-04 | 1353 | 157 | 22 | GO:0004888 |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 9.66e-04 | 25 | 157 | 3 | GO:0015149 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 9.66e-04 | 25 | 157 | 3 | GO:0055056 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP13A4 RRAS2 ABCA1 RHOJ RRAS DHX8 CLU RND2 GNAS KIF13A CDC42 DNAH6 KIF17 DNAH8 GNL1 | 1.20e-03 | 775 | 157 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 1.21e-03 | 27 | 157 | 3 | GO:0015145 | |
| GeneOntologyMolecularFunction | glycerol channel activity | 1.26e-03 | 7 | 157 | 2 | GO:0015254 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 1.50e-03 | 29 | 157 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | clathrin binding | 1.53e-03 | 63 | 157 | 4 | GO:0030276 | |
| GeneOntologyMolecularFunction | carbohydrate:proton symporter activity | 1.67e-03 | 8 | 157 | 2 | GO:0005351 | |
| GeneOntologyMolecularFunction | urea transmembrane transporter activity | 2.13e-03 | 9 | 157 | 2 | GO:0015204 | |
| GeneOntologyMolecularFunction | glycerol transmembrane transporter activity | 2.13e-03 | 9 | 157 | 2 | GO:0015168 | |
| GeneOntologyMolecularFunction | urate transmembrane transporter activity | 2.13e-03 | 9 | 157 | 2 | GO:0015143 | |
| GeneOntologyMolecularFunction | salt transmembrane transporter activity | 2.13e-03 | 9 | 157 | 2 | GO:1901702 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.25e-03 | 70 | 157 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP13A4 RRAS2 ABCA1 RHOJ RRAS DHX8 CLU RND2 GNAS KIF13A CDC42 DNAH6 KIF17 DNAH8 GNL1 | 2.59e-03 | 839 | 157 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 2.60e-03 | 35 | 157 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP13A4 RRAS2 ABCA1 RHOJ RRAS DHX8 CLU RND2 GNAS KIF13A CDC42 DNAH6 KIF17 DNAH8 GNL1 | 2.61e-03 | 840 | 157 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP13A4 RRAS2 ABCA1 RHOJ RRAS DHX8 CLU RND2 GNAS KIF13A CDC42 DNAH6 KIF17 DNAH8 GNL1 | 2.61e-03 | 840 | 157 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | modified amino acid binding | 2.79e-03 | 122 | 157 | 5 | GO:0072341 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SCN11A KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 | 3.48e-03 | 459 | 157 | 10 | GO:0005216 |
| GeneOntologyBiologicalProcess | negative regulation of cytosolic calcium ion concentration | 1.13e-06 | 25 | 157 | 5 | GO:0051481 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SCN11A DRD2 RHOJ ANXA7 PCDHAC2 SEMA5A ECE1 CDH19 TENM2 BTBD3 SLC39A12 SIDT2 CDH22 CLU NFIX CNTNAP2 DOCK7 SYT1 SYT4 AFDN RND2 FGR CDC42 CNTN2 PLXNB1 | 3.87e-06 | 1194 | 157 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | GPBAR1 GPRASP1 SCN11A ABCA1 DRD2 DRD3 PDGFRL OR4D9 ANXA7 OPN1LW OR5M11 OR2T34 ECE1 ACE OR2T11 ADCY3 OR6N1 OR2T3 OR2B11 GPR158 LPAR6 TMEM145 GNAS CDC42 NOS1 ADGRL3 CNTN2 | 6.49e-06 | 1395 | 157 | 27 | GO:0007186 |
| GeneOntologyBiologicalProcess | Cdc42 protein signal transduction | 7.12e-06 | 17 | 157 | 4 | GO:0032488 | |
| GeneOntologyBiologicalProcess | potassium ion transport | DRD2 DRD3 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 KCNK3 KCNMA1 NOS1 | 7.84e-06 | 272 | 157 | 11 | GO:0006813 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SCN11A DRD2 PCDHAC2 SEMA5A ECE1 TENM2 BTBD3 SLC39A12 CLU NFIX CNTNAP2 DOCK7 SYT1 SYT4 AFDN RND2 CDC42 CNTN2 PLXNB1 | 1.17e-05 | 802 | 157 | 19 | GO:0048812 |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | CA9 SCN11A AQP10 DRD2 DRD3 MYO6 ANXA7 TMEM135 OPN1LW SEMA5A TXNRD2 ECE1 ACE NPHP4 USP19 SLC39A12 KCNA1 KCNA5 PTPRK AIFM1 PKD1 CNTNAP2 KCNK3 KCNMA1 MYO15A NOS1 | 1.24e-05 | 1361 | 157 | 26 | GO:0009628 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SCN11A DRD2 PCDHAC2 SEMA5A ECE1 TENM2 BTBD3 SLC39A12 CLU NFIX CNTNAP2 DOCK7 SYT1 SYT4 AFDN RND2 CDC42 CNTN2 PLXNB1 | 1.56e-05 | 819 | 157 | 19 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SCN11A DRD2 PCDHAC2 SEMA5A ECE1 TENM2 BTBD3 SLC39A12 CLU NFIX CNTNAP2 DOCK7 SYT1 SYT4 AFDN RND2 CDC42 CNTN2 PLXNB1 | 1.76e-05 | 826 | 157 | 19 | GO:0048858 |
| GeneOntologyBiologicalProcess | endocytosis | ABCA1 DRD2 DRD3 RHOJ MYO6 NCF4 TFR2 SYT8 CLU MRC2 NFIX SYT1 SYT4 SYT5 FGR MYO15A CDC42 ARHGAP21 CNTN2 | 1.79e-05 | 827 | 157 | 19 | GO:0006897 |
| GeneOntologyBiologicalProcess | positive regulation of G protein-coupled receptor signaling pathway | 2.05e-05 | 44 | 157 | 5 | GO:0045745 | |
| GeneOntologyBiologicalProcess | import into cell | ABCA1 DRD2 DRD3 RHOJ MYO6 NCF4 TFR2 SLC39A12 SYT8 CLU MRC2 NFIX KCNJ13 SYT1 SYT4 SYT5 FGR MYO15A CDC42 NOS1 ARHGAP21 CNTN2 | 2.21e-05 | 1074 | 157 | 22 | GO:0098657 |
| GeneOntologyBiologicalProcess | metal ion transport | ATP13A4 SCN11A DRD2 DRD3 SLC5A9 ACE TFR2 GJA4 SLC39A12 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 NIPA2 GNAS NOS1 | 2.40e-05 | 1000 | 157 | 21 | GO:0030001 |
| GeneOntologyBiologicalProcess | cell junction assembly | GPBAR1 DRD2 MYO6 CDH19 ACE NPHP4 GJA4 CDH22 PTPRK CNTNAP2 DOCK7 AFDN CDC42 ADGRL3 PLXNB1 | 3.08e-05 | 569 | 157 | 15 | GO:0034329 |
| GeneOntologyBiologicalProcess | calcium ion-regulated exocytosis of neurotransmitter | 3.61e-05 | 25 | 157 | 4 | GO:0048791 | |
| GeneOntologyBiologicalProcess | Rho protein signal transduction | 3.77e-05 | 164 | 157 | 8 | GO:0007266 | |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 4.29e-05 | 167 | 157 | 8 | GO:0007043 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | CA9 SCN11A ABCA1 DRD2 DRD3 MYO6 TXNRD2 ACE CCNT1 CNTNAP2 KCNK3 UGT2B7 GNAS NOS1 | 5.05e-05 | 525 | 157 | 14 | GO:0009410 |
| GeneOntologyBiologicalProcess | secretion | CA9 SCN11A ABCA1 DRD2 DRD3 A1CF MYO6 ADAM9 ANXA7 ACE AQP9 TFR2 SIDT2 KCNA5 SYT8 GPR158 KCNMA1 SYT1 SYT4 SYT5 GNAS FGR NOS1 | 5.21e-05 | 1221 | 157 | 23 | GO:0046903 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP13A4 SCN11A DRD2 DRD3 SLC2A9 SLC5A9 ACE TFR2 GJA4 SLC39A12 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 NIPA2 GNAS NOS1 | 6.72e-05 | 1157 | 157 | 22 | GO:0006812 |
| GeneOntologyBiologicalProcess | phasic smooth muscle contraction | 7.59e-05 | 30 | 157 | 4 | GO:0014821 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 9.67e-05 | 358 | 157 | 11 | GO:0015850 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1.10e-04 | 191 | 157 | 8 | GO:0007189 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 1.15e-04 | 246 | 157 | 9 | GO:0045216 | |
| GeneOntologyBiologicalProcess | regulation of dopamine secretion | 1.25e-04 | 34 | 157 | 4 | GO:0014059 | |
| GeneOntologyBiologicalProcess | response to fluid shear stress | 1.41e-04 | 35 | 157 | 4 | GO:0034405 | |
| GeneOntologyBiologicalProcess | response to alcohol | 1.43e-04 | 312 | 157 | 10 | GO:0097305 | |
| GeneOntologyBiologicalProcess | response to laminar fluid shear stress | 1.48e-04 | 14 | 157 | 3 | GO:0034616 | |
| GeneOntologyBiologicalProcess | action potential | 1.57e-04 | 201 | 157 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | substance P catabolic process | 1.72e-04 | 3 | 157 | 2 | GO:0010814 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity directed against tumor cell target | 1.72e-04 | 3 | 157 | 2 | GO:0002852 | |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 1.82e-04 | 69 | 157 | 5 | GO:0031279 | |
| GeneOntologyBiologicalProcess | retrograde trans-synaptic signaling | 1.84e-04 | 15 | 157 | 3 | GO:0098917 | |
| GeneOntologyBiologicalProcess | sensory perception | SCN11A DRD2 MYO6 OR4D9 OPN1LW SEMA5A OR5M11 OR2T34 OR2T11 PKHD1L1 ADCY3 OR6N1 OR2T3 GFY OR2B11 KCNA1 KCNMA1 GNAS MYO15A USH2A | 1.91e-04 | 1072 | 157 | 20 | GO:0007600 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ATP13A4 SCN11A DRD2 DRD3 SLC2A9 SLC5A9 SLC39A12 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 NIPA2 NOS1 | 2.36e-04 | 922 | 157 | 18 | GO:0098662 |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 2.37e-04 | 73 | 157 | 5 | GO:0051339 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | RRAS2 ABCA1 WAS RHOJ RRAS NFIX LPAR6 DOCK7 ROPN1B RND2 CDC42 ARHGAP21 PLXNB1 | 2.49e-04 | 538 | 157 | 13 | GO:0007264 |
| GeneOntologyBiologicalProcess | dopamine secretion | 2.63e-04 | 41 | 157 | 4 | GO:0014046 | |
| GeneOntologyBiologicalProcess | startle response | 2.63e-04 | 41 | 157 | 4 | GO:0001964 | |
| GeneOntologyBiologicalProcess | locomotion involved in locomotory behavior | 2.72e-04 | 17 | 157 | 3 | GO:0031987 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ATP13A4 SCN11A DRD2 DRD3 SLC2A9 SLC5A9 SLC4A1 SLC39A12 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 NIPA2 NOS1 | 2.74e-04 | 1017 | 157 | 19 | GO:0098660 |
| GeneOntologyBiologicalProcess | neuron development | SCN11A DRD2 MYO6 PCDHAC2 SEMA5A ECE1 NPHP4 TENM2 BTBD3 SLC39A12 KCNA1 PTPRK CLU NFIX CNTNAP2 DOCK7 KCNMA1 SYT1 SYT4 AFDN RND2 CDC42 CNTN2 PLXNB1 | 2.93e-04 | 1463 | 157 | 24 | GO:0048666 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ATP13A4 SCN11A DRD2 DRD3 SLC2A9 SLC5A9 ACE SLC4A1 TFR2 GJA4 SLC39A12 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 NIPA2 GNAS NOS1 | 2.98e-04 | 1374 | 157 | 23 | GO:0006811 |
| GeneOntologyBiologicalProcess | neuron projection development | SCN11A DRD2 MYO6 PCDHAC2 SEMA5A ECE1 TENM2 BTBD3 SLC39A12 KCNA1 PTPRK CLU NFIX CNTNAP2 DOCK7 SYT1 SYT4 AFDN RND2 CDC42 CNTN2 PLXNB1 | 3.00e-04 | 1285 | 157 | 22 | GO:0031175 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATP13A4 SCN11A DRD2 DRD3 SLC2A9 SLC5A9 SLC39A12 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 NIPA2 NOS1 | 3.06e-04 | 942 | 157 | 18 | GO:0098655 |
| GeneOntologyBiologicalProcess | establishment of protein localization to extracellular region | ABCA1 DRD2 DRD3 A1CF ADAM9 ANXA7 SIDT2 KCNA5 SYT4 LTBP1 GNAS NOS1 | 3.36e-04 | 483 | 157 | 12 | GO:0035592 |
| GeneOntologyBiologicalProcess | negative regulation of dopamine receptor signaling pathway | 3.42e-04 | 4 | 157 | 2 | GO:0060160 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | SCN11A DRD2 TMEM135 KCNA1 KCNA5 KCNA6 KCNA10 NALCN CNTNAP2 KCNK3 KCNMA1 AFDN NOS1 | 3.59e-04 | 559 | 157 | 13 | GO:0042391 |
| GeneOntologyBiologicalProcess | regulation of protein secretion | 3.60e-04 | 350 | 157 | 10 | GO:0050708 | |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | ABCA1 DRD2 DRD3 A1CF ADAM9 ANXA7 SIDT2 KCNA5 SYT4 LTBP1 GNAS NOS1 | 3.83e-04 | 490 | 157 | 12 | GO:0071692 |
| GeneOntologyBiologicalProcess | anatomical structure maturation | NFIX CNTNAP2 KCNMA1 SYT4 CATSPERB ROPN1B RFLNA FUT6 CNTN2 PLXNB1 | 3.93e-04 | 354 | 157 | 10 | GO:0071695 |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 4.12e-04 | 232 | 157 | 8 | GO:0071805 | |
| GeneOntologyBiologicalProcess | regulation of secretion | DRD2 DRD3 A1CF MYO6 ADAM9 ANXA7 TFR2 SIDT2 KCNA5 GPR158 SYT1 SYT4 SYT5 GNAS FGR NOS1 | 4.14e-04 | 801 | 157 | 16 | GO:0051046 |
| GeneOntologyBiologicalProcess | acrosome reaction | 4.47e-04 | 47 | 157 | 4 | GO:0007340 | |
| GeneOntologyBiologicalProcess | prepulse inhibition | 4.48e-04 | 20 | 157 | 3 | GO:0060134 | |
| GeneOntologyBiologicalProcess | synaptic signaling | DRD2 DRD3 MYO6 ANXA7 ACE TENM2 SYT8 NALCN GPR158 CNTNAP2 KCNK3 KCNMA1 SYT1 SYT4 AFDN SYT5 NOS1 CNTN2 | 4.66e-04 | 976 | 157 | 18 | GO:0099536 |
| GeneOntologyBiologicalProcess | response to oxygen levels | CA9 DRD2 TXNRD2 ECE1 ACE USP19 SLC39A12 KCNA5 AIFM1 KCNK3 KCNMA1 | 4.67e-04 | 430 | 157 | 11 | GO:0070482 |
| GeneOntologyBiologicalProcess | secretion by cell | SCN11A ABCA1 DRD2 DRD3 A1CF MYO6 ADAM9 ANXA7 TFR2 SIDT2 KCNA5 SYT8 GPR158 SYT1 SYT4 SYT5 GNAS FGR NOS1 | 4.79e-04 | 1064 | 157 | 19 | GO:0032940 |
| GeneOntologyBiologicalProcess | signal release | ABCA1 DRD2 DRD3 ANXA7 TFR2 SIDT2 KCNA5 SYT8 GPR158 SYT1 SYT4 SYT5 GNAS NOS1 | 4.81e-04 | 653 | 157 | 14 | GO:0023061 |
| GeneOntologyBiologicalProcess | regulation of G protein-coupled receptor signaling pathway | 4.81e-04 | 181 | 157 | 7 | GO:0008277 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 4.85e-04 | 130 | 157 | 6 | GO:0097306 | |
| GeneOntologyBiologicalProcess | cellular response to ketone | 4.85e-04 | 130 | 157 | 6 | GO:1901655 | |
| GeneOntologyBiologicalProcess | export from cell | SCN11A ABCA1 DRD2 DRD3 A1CF MYO6 ADAM9 ANXA7 TFR2 SIDT2 KCNA5 SYT8 GPR158 PKD1 SYT1 SYT4 SYT5 GNAS FGR NOS1 | 4.88e-04 | 1153 | 157 | 20 | GO:0140352 |
| GeneOntologyBiologicalProcess | response to decreased oxygen levels | 4.89e-04 | 364 | 157 | 10 | GO:0036293 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | DRD2 DRD3 A1CF ADAM9 ANXA7 TFR2 SIDT2 KCNA5 GPR158 SYT1 SYT4 SYT5 GNAS FGR NOS1 | 5.42e-04 | 740 | 157 | 15 | GO:1903530 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 PCDHGA10 ADAM9 PCDHAC2 IGSF5 CDH19 NPHP4 TENM2 ITGB5 SLC4A1 CDH22 PKD1 ROPN1B AFDN GNAS CDC42 MUC4 ADGRL3 CNTN2 | 5.55e-04 | 1077 | 157 | 19 | GO:0098609 |
| GeneOntologyBiologicalProcess | neuropeptide catabolic process | 5.67e-04 | 5 | 157 | 2 | GO:0010813 | |
| GeneOntologyBiologicalProcess | atrioventricular canal morphogenesis | 5.67e-04 | 5 | 157 | 2 | GO:1905222 | |
| GeneOntologyBiologicalProcess | protein localization to juxtaparanode region of axon | 5.67e-04 | 5 | 157 | 2 | GO:0071205 | |
| GeneOntologyBiologicalProcess | action potential initiation | 5.67e-04 | 5 | 157 | 2 | GO:0099610 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 5.85e-04 | 187 | 157 | 7 | GO:0007156 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SCN11A DRD2 PCDHAC2 SEMA5A ECE1 TENM2 BTBD3 NFIX CNTNAP2 DOCK7 AFDN RND2 CDC42 CNTN2 PLXNB1 | 6.05e-04 | 748 | 157 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | response to pain | 6.11e-04 | 51 | 157 | 4 | GO:0048265 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 6.77e-04 | 313 | 157 | 9 | GO:0098742 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 7.44e-04 | 141 | 157 | 6 | GO:0051588 | |
| GeneOntologyBiologicalProcess | response to ketone | 7.48e-04 | 254 | 157 | 8 | GO:1901654 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | PLB1 DRD2 ANXA7 H6PD ECE1 RETSAT ACE TFR2 SIDT2 KCNA5 KCNMA1 UGT2B7 GNAS NOS1 | 7.57e-04 | 684 | 157 | 14 | GO:0010817 |
| GeneOntologyBiologicalProcess | behavioral response to cocaine | 7.79e-04 | 24 | 157 | 3 | GO:0048148 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter uptake | 7.79e-04 | 24 | 157 | 3 | GO:0051580 | |
| GeneOntologyBiologicalProcess | positive regulation of cytokinesis | 8.15e-04 | 55 | 157 | 4 | GO:0032467 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | DRD2 DRD3 MYO6 ACE TENM2 SYT8 NALCN GPR158 CNTNAP2 KCNK3 KCNMA1 SYT1 SYT4 AFDN SYT5 NOS1 CNTN2 | 8.27e-04 | 939 | 157 | 17 | GO:0099537 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ATP13A4 SCN11A DRD2 DRD3 SLC2A9 SLC5A9 SLC4A1 SLC39A12 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 KCNK3 KCNMA1 NIPA2 NOS1 | 8.41e-04 | 1115 | 157 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting dopamine receptor signaling pathway | 8.46e-04 | 6 | 157 | 2 | GO:0007195 | |
| GeneOntologyBiologicalProcess | clustering of voltage-gated potassium channels | 8.46e-04 | 6 | 157 | 2 | GO:0045163 | |
| GeneOntologyBiologicalProcess | small intestine smooth muscle contraction | 8.46e-04 | 6 | 157 | 2 | GO:1990770 | |
| GeneOntologyBiologicalProcess | cerebral cortex GABAergic interneuron migration | 8.46e-04 | 6 | 157 | 2 | GO:0021853 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity directed against tumor cell target | 8.46e-04 | 6 | 157 | 2 | GO:0002419 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 8.49e-04 | 259 | 157 | 8 | GO:0006836 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating adrenergic receptor signaling pathway | 8.80e-04 | 25 | 157 | 3 | GO:0071880 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | DRD2 OR4D9 OR5M11 OR2T34 OR2T11 ADCY3 OR6N1 OR2T3 GFY OR2B11 GNAS | 8.90e-04 | 465 | 157 | 11 | GO:0007608 |
| GeneOntologyBiologicalProcess | dopamine transport | 9.33e-04 | 57 | 157 | 4 | GO:0015872 | |
| GeneOntologyBiologicalProcess | regulation of cytokinesis | 9.64e-04 | 99 | 157 | 5 | GO:0032465 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 1.06e-03 | 59 | 157 | 4 | GO:0045761 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion by cell | 1.08e-03 | 404 | 157 | 10 | GO:1903532 | |
| GeneOntologyBiologicalProcess | walking behavior | 1.13e-03 | 60 | 157 | 4 | GO:0090659 | |
| GeneOntologyBiologicalProcess | protein secretion | 1.15e-03 | 480 | 157 | 11 | GO:0009306 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 1.15e-03 | 210 | 157 | 7 | GO:0060294 | |
| GeneOntologyBiologicalProcess | bradykinin catabolic process | 1.18e-03 | 7 | 157 | 2 | GO:0010815 | |
| GeneOntologyBiologicalProcess | adherens junction organization | 1.20e-03 | 61 | 157 | 4 | GO:0034332 | |
| GeneOntologyBiologicalProcess | cell junction organization | GPBAR1 DRD2 MYO6 CDH19 ACE NPHP4 GJA4 CDH22 PTPRK GPR158 CNTNAP2 DOCK7 AFDN CDC42 ADGRL3 CNTN2 PLXNB1 | 1.23e-03 | 974 | 157 | 17 | GO:0034330 |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 RRAS2 WAS ADAM9 IGSF5 RRAS CDH19 NPHP4 TENM2 ITGB5 SLC4A1 GJA4 CDH22 KCNA1 KCNA5 PTPRK MRC2 CNTNAP2 DOCK7 AFDN CDC42 ARHGAP21 ADGRL3 | 9.94e-07 | 976 | 156 | 23 | GO:0070161 |
| GeneOntologyCellularComponent | axon | SCN11A DRD2 MYO6 TXNRD2 TENM2 KCNA1 KCNA6 SYT8 PTPRK CLU CNTNAP2 DOCK7 KCNMA1 SYT1 SYT4 AFDN SYT5 USH2A NOS1 ADGRL3 CNTN2 | 3.08e-06 | 891 | 156 | 21 | GO:0030424 |
| GeneOntologyCellularComponent | chromaffin granule | 3.82e-06 | 15 | 156 | 4 | GO:0042583 | |
| GeneOntologyCellularComponent | apical part of cell | AQP10 PLB1 DRD3 SLC2A9 MYO6 IGSF5 KCNA1 KCNA5 SLC22A13 NPC1L1 KCNMA1 AFDN GNAS CDC42 USH2A MUC4 | 9.52e-06 | 592 | 156 | 16 | GO:0045177 |
| GeneOntologyCellularComponent | chromaffin granule membrane | 3.31e-05 | 9 | 156 | 3 | GO:0042584 | |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 WAS IGSF5 CDH19 NPHP4 TENM2 SLC4A1 GJA4 CDH22 KCNA5 PTPRK CNTNAP2 AFDN CDC42 ADGRL3 | 3.79e-05 | 591 | 156 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 6.20e-05 | 91 | 156 | 6 | GO:0008076 | |
| GeneOntologyCellularComponent | cation channel complex | SCN11A KCNA1 KCNA5 KCNA6 KCNA10 PKD1 CNTNAP2 KCNMA1 CATSPERB | 7.01e-05 | 235 | 156 | 9 | GO:0034703 |
| GeneOntologyCellularComponent | juxtaparanode region of axon | 8.54e-05 | 12 | 156 | 3 | GO:0044224 | |
| GeneOntologyCellularComponent | cell projection membrane | CA9 PLB1 DRD2 MYO6 ACE ADCY3 NPC1L1 PKD1 CNTNAP2 FGR USH2A MUC4 | 9.83e-05 | 431 | 156 | 12 | GO:0031253 |
| GeneOntologyCellularComponent | potassium channel complex | 1.30e-04 | 104 | 156 | 6 | GO:0034705 | |
| GeneOntologyCellularComponent | basal part of cell | CA9 AQP10 ABCA1 SLC2A9 ADAM9 ACE AQP9 SLC4A1 PKD1 DOCK7 SVOP | 1.31e-04 | 378 | 156 | 11 | GO:0045178 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | SCN11A KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 CNTNAP2 KCNMA1 CATSPERB | 1.31e-04 | 378 | 156 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | plasma membrane protein complex | SCN11A DRD2 NCF4 CDH19 ITGB5 TFR2 GJA4 CDH22 KCNA1 KCNA5 KCNA6 KCNA10 CNTNAP2 KCNMA1 CATSPERB GNAS | 2.66e-04 | 785 | 156 | 16 | GO:0098797 |
| GeneOntologyCellularComponent | apical plasma membrane | AQP10 PLB1 SLC2A9 IGSF5 KCNA1 KCNA5 SLC22A13 NPC1L1 KCNMA1 GNAS USH2A MUC4 | 3.03e-04 | 487 | 156 | 12 | GO:0016324 |
| GeneOntologyCellularComponent | basal plasma membrane | 3.37e-04 | 354 | 156 | 10 | GO:0009925 | |
| GeneOntologyCellularComponent | presynapse | SCN11A DRD2 MYO6 KCNA1 KCNA6 SYT8 GPR158 CNTNAP2 KCNMA1 SYT1 SYT4 AFDN SYT5 EGFLAM USH2A NOS1 SVOP | 3.44e-04 | 886 | 156 | 17 | GO:0098793 |
| GeneOntologyCellularComponent | neuron projection terminus | 3.72e-04 | 233 | 156 | 8 | GO:0044306 | |
| GeneOntologyCellularComponent | synaptic membrane | SCN11A DRD2 DRD3 TENM2 ITGB5 KCNA1 GPR158 CNTNAP2 KCNMA1 SYT1 AFDN ADGRL3 CNTN2 | 4.43e-04 | 583 | 156 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | dense core granule | 8.11e-04 | 56 | 156 | 4 | GO:0031045 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 8.14e-04 | 6 | 156 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | neuronal dense core vesicle membrane | 8.14e-04 | 6 | 156 | 2 | GO:0099012 | |
| GeneOntologyCellularComponent | somatodendritic compartment | SCN11A DRD2 MYO6 TXNRD2 TENM2 KCNA1 PTPRK CLU CNTNAP2 KCNMA1 SYT4 AFDN SYT5 LTBP1 GNAS CDC42 USH2A KIF17 NOS1 CNTN2 | 8.35e-04 | 1228 | 156 | 20 | GO:0036477 |
| GeneOntologyCellularComponent | presynaptic membrane | 1.15e-03 | 277 | 156 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | actin-based cell projection | 1.18e-03 | 278 | 156 | 8 | GO:0098858 | |
| GeneOntologyCellularComponent | axon initial segment | 1.29e-03 | 29 | 156 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.46e-03 | 223 | 156 | 7 | GO:0098862 | |
| GeneOntologyCellularComponent | neuronal cell body | SCN11A DRD2 MYO6 TXNRD2 KCNA1 PTPRK CNTNAP2 KCNMA1 SYT4 SYT5 LTBP1 GNAS CDC42 USH2A CNTN2 | 1.49e-03 | 835 | 156 | 15 | GO:0043025 |
| GeneOntologyCellularComponent | distal axon | 1.62e-03 | 435 | 156 | 10 | GO:0150034 | |
| GeneOntologyCellularComponent | ribbon synapse | 1.73e-03 | 32 | 156 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | SCN11A KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 CNTNAP2 KCNMA1 CATSPERB | 1.94e-03 | 523 | 156 | 11 | GO:1902495 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 2.11e-03 | 238 | 156 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 2.28e-03 | 179 | 156 | 6 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 2.28e-03 | 179 | 156 | 6 | GO:0030672 | |
| GeneOntologyCellularComponent | dense core granule membrane | 2.39e-03 | 10 | 156 | 2 | GO:0032127 | |
| GeneOntologyCellularComponent | endocytic vesicle | 2.42e-03 | 384 | 156 | 9 | GO:0030139 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 2.83e-03 | 320 | 156 | 8 | GO:0016323 | |
| GeneOntologyCellularComponent | transporter complex | SCN11A KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 CNTNAP2 KCNMA1 CATSPERB | 2.85e-03 | 550 | 156 | 11 | GO:1990351 |
| GeneOntologyCellularComponent | cilium | DRD2 OPN1LW ACE NPHP4 ADCY3 ADGB PTPRK PKD1 CATSPERB ROPN1B USH2A DNAH6 KIF17 DNAH8 CFAP46 | 3.00e-03 | 898 | 156 | 15 | GO:0005929 |
| GeneOntologyCellularComponent | glutamatergic synapse | SCN11A DRD2 DRD3 MYO6 TENM2 ITGB5 KCNA1 CNTNAP2 KCNMA1 SYT1 SYT4 CDC42 NOS1 ADGRL3 | 3.28e-03 | 817 | 156 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.45e-03 | 405 | 156 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | non-motile cilium | 3.58e-03 | 196 | 156 | 6 | GO:0097730 | |
| GeneOntologyCellularComponent | secretory granule | DRD2 ANXA7 HRNR ECE1 F13A1 SYT8 CLU AGL SYT1 SYT4 SYT5 RND2 FGR CDC42 NOS1 CYB561 | 3.83e-03 | 1014 | 156 | 16 | GO:0030141 |
| GeneOntologyCellularComponent | membrane protein complex | SCN11A DRD2 NCF4 CDH19 ITGB5 SLC4A1 TFR2 GJA4 CDH22 KCNA1 KCNA5 KCNA6 KCNA10 NALCN KCNJ13 PKD1 CNTNAP2 KCNMA1 CATSPERB AFDN GNAS | 3.85e-03 | 1498 | 156 | 21 | GO:0098796 |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 3.92e-03 | 139 | 156 | 5 | GO:0097733 | |
| GeneOntologyCellularComponent | cell surface | ABCA1 ADAM9 IGSF5 ECE1 ACE ITGB5 SLC4A1 TFR2 KCNA1 KCNA5 PTPRK CLU MRC2 PKD1 CNTNAP2 KCNMA1 CNTN2 | 3.94e-03 | 1111 | 156 | 17 | GO:0009986 |
| GeneOntologyCellularComponent | postsynapse | DRD2 DRD3 MYO6 TENM2 TFR2 KCNA1 GPR158 CNTNAP2 KCNMA1 SYT4 AFDN CDC42 KIF17 NOS1 ADGRL3 CNTN2 | 3.97e-03 | 1018 | 156 | 16 | GO:0098794 |
| GeneOntologyCellularComponent | cell body | SCN11A DRD2 MYO6 TXNRD2 KCNA1 PTPRK CNTNAP2 KCNMA1 SYT4 SYT5 LTBP1 GNAS CDC42 USH2A CNTN2 | 4.11e-03 | 929 | 156 | 15 | GO:0044297 |
| GeneOntologyCellularComponent | axon terminus | 5.00e-03 | 210 | 156 | 6 | GO:0043679 | |
| GeneOntologyCellularComponent | leading edge membrane | 5.00e-03 | 210 | 156 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | dendrite | DRD2 TXNRD2 TENM2 KCNA1 PTPRK CLU CNTNAP2 KCNMA1 SYT4 LTBP1 GNAS CDC42 KIF17 NOS1 | 5.05e-03 | 858 | 156 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DRD2 TXNRD2 TENM2 KCNA1 PTPRK CLU CNTNAP2 KCNMA1 SYT4 LTBP1 GNAS CDC42 KIF17 NOS1 | 5.15e-03 | 860 | 156 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | motile cilium | 5.28e-03 | 355 | 156 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | sperm flagellum | 5.47e-03 | 214 | 156 | 6 | GO:0036126 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 5.51e-03 | 48 | 156 | 3 | GO:0032391 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 5.86e-03 | 153 | 156 | 5 | GO:0097731 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 6.53e-03 | 157 | 156 | 5 | GO:0045335 | |
| GeneOntologyCellularComponent | paranode region of axon | 6.99e-03 | 17 | 156 | 2 | GO:0033270 | |
| MousePheno | abnormal nervous system electrophysiology | SCN11A DRD2 MYO6 KCNA1 KCNA5 NALCN TPH2 CNTNAP2 KCNK3 KCNMA1 RND2 NOS1 RAI1 | 1.18e-05 | 329 | 130 | 13 | MP:0002272 |
| Domain | K_chnl_volt-dep_Kv1 | 2.88e-07 | 8 | 152 | 4 | IPR003972 | |
| Domain | VG_K_chnl | 6.60e-06 | 33 | 152 | 5 | IPR028325 | |
| Domain | Channel_four-helix_dom | 6.78e-06 | 57 | 152 | 6 | IPR027359 | |
| Domain | - | 6.78e-06 | 57 | 152 | 6 | 1.20.120.350 | |
| Domain | Synaptotagmin | 1.85e-05 | 20 | 152 | 4 | IPR001565 | |
| Domain | Ion_trans_dom | 4.09e-05 | 114 | 152 | 7 | IPR005821 | |
| Domain | Ion_trans | 4.09e-05 | 114 | 152 | 7 | PF00520 | |
| Domain | K_chnl_volt-dep_Kv | 6.40e-05 | 27 | 152 | 4 | IPR003968 | |
| Pubmed | Physical mapping of potassium channel gene clusters on mouse chromosomes three and six. | 6.11e-09 | 6 | 158 | 4 | 9286706 | |
| Pubmed | 1.42e-08 | 7 | 158 | 4 | 27619418 | ||
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 15197251 | ||
| Pubmed | R-Ras controls axon branching through afadin in cortical neurons. | 9.20e-08 | 3 | 158 | 3 | 22593211 | |
| Pubmed | Characterization of a voltage-activated K-channel gene cluster on human chromosome 12p13. | 9.20e-08 | 3 | 158 | 3 | 8821794 | |
| Pubmed | 1.32e-07 | 11 | 158 | 4 | 10734137 | ||
| Pubmed | 1.32e-07 | 11 | 158 | 4 | 18786395 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 18760366 | ||
| Pubmed | Characterization of TCL, a new GTPase of the rho family related to TC10 andCcdc42. | 9.14e-07 | 5 | 158 | 3 | 10967094 | |
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 20446882 | ||
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 21233214 | ||
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 12963709 | ||
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 10224125 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | CFHR1 EXTL1 H6PD HRNR OR2T34 ECE1 UBE2U OR6N1 OR2T3 OR2B11 GJA4 DOCK7 SLC45A1 FGR CDC42 USH2A KIF17 CNTN2 | 1.17e-06 | 1031 | 158 | 18 | 16710414 |
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 8626542 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 8530061 | ||
| Pubmed | 2.31e-06 | 21 | 158 | 4 | 25707359 | ||
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 22229870 | ||
| Pubmed | A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms. | 3.18e-06 | 7 | 158 | 3 | 19506579 | |
| Pubmed | Postsynaptic density-93 clusters Kv1 channels at axon initial segments independently of Caspr2. | 3.18e-06 | 7 | 158 | 3 | 18509034 | |
| Pubmed | KCNE2 forms potassium channels with KCNA3 and KCNQ1 in the choroid plexus epithelium. | 5.07e-06 | 8 | 158 | 3 | 21859894 | |
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 10531343 | ||
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 8901523 | ||
| Pubmed | Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. | 1.08e-05 | 10 | 158 | 3 | 9914469 | |
| Pubmed | Developmental expression of voltage-sensitive K+ channels in mouse skeletal muscle and C2C12 cells. | 1.08e-05 | 10 | 158 | 3 | 1383027 | |
| Pubmed | Voltage-gated potassium channel genes are clustered in paralogous regions of the mouse genome. | 1.17e-05 | 31 | 158 | 4 | 8034307 | |
| Pubmed | ADCY3 SLC4A1 KCNA1 KCNA6 GPR158 AIFM1 TMEM145 CDC42 SVOP ARHGAP21 | 1.78e-05 | 405 | 158 | 10 | 38187761 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 12834818 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 22970199 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 20970071 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 27349735 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 23305686 | ||
| Pubmed | Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD. | 2.05e-05 | 2 | 158 | 2 | 11425949 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 20188195 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 31538542 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 33318558 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 17175177 | ||
| Pubmed | Association study of dopamine D2 and D3 receptor gene polymorphisms with cocaine dependence. | 2.05e-05 | 2 | 158 | 2 | 16094250 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19011428 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 15537671 | ||
| Pubmed | Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. | 2.05e-05 | 2 | 158 | 2 | 21663922 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26819282 | ||
| Pubmed | Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity. | 2.05e-05 | 2 | 158 | 2 | 24785761 | |
| Pubmed | Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors. | 2.05e-05 | 2 | 158 | 2 | 10391470 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19669131 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 23954846 | ||
| Pubmed | Latent-Profile Analysis Reveals Behavioral and Brain Correlates of Dopamine-Cognition Associations. | 2.05e-05 | 2 | 158 | 2 | 29028935 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26217189 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 27018747 | ||
| Pubmed | Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface. | 2.05e-05 | 2 | 158 | 2 | 22291025 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 25641350 | ||
| Pubmed | Synaptotagmin IV regulates dense core vesicle (DCV) release in LbetaT2 cells. | 2.05e-05 | 2 | 158 | 2 | 18468511 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 32166738 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 27184782 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 23154100 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 32083297 | ||
| Pubmed | Posterior dopamine D2/3 receptors and brain network functional connectivity. | 2.05e-05 | 2 | 158 | 2 | 28700819 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 10506202 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 23683269 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26199228 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19457373 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 21844200 | ||
| Pubmed | G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors. | 2.05e-05 | 2 | 158 | 2 | 18218829 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 18410503 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 18987627 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 18481021 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 15102843 | ||
| Pubmed | R-Ras1 and R-Ras2 Expression in Anatomical Regions and Cell Types of the Central Nervous System. | 2.05e-05 | 2 | 158 | 2 | 35055164 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26944295 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 31943514 | ||
| Pubmed | Examining the Effects of Sodium Ions on the Binding of Antagonists to Dopamine D2 and D3 Receptors. | 2.05e-05 | 2 | 158 | 2 | 27379794 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 22591910 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 22234337 | ||
| Pubmed | The RCK2 domain of the human BKCa channel is a calcium sensor. | 2.05e-05 | 2 | 158 | 2 | 18162557 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 10360578 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 16759339 | ||
| Pubmed | The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain. | 2.05e-05 | 2 | 158 | 2 | 8313980 | |
| Pubmed | New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion. | 2.05e-05 | 2 | 158 | 2 | 30626912 | |
| Pubmed | Interaction between SIDT2 and ABCA1 Variants with Nutrients on HDL-c Levels in Mexican Adults. | 2.05e-05 | 2 | 158 | 2 | 36678241 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 27634830 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 33039854 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 34349232 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 9660763 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19217026 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 23884939 | ||
| Pubmed | Multiple mRNA isoforms encoding the mouse cardiac Kv1-5 delayed rectifier K+ channel. | 2.05e-05 | 2 | 158 | 2 | 8226976 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 25289757 | ||
| Pubmed | Mapping the landscape of human dopamine D2/3 receptors with [11C]raclopride. | 2.05e-05 | 2 | 158 | 2 | 31444615 | |
| Pubmed | Genetic variants in autism-related CNTNAP2 impair axonal growth of cortical neurons. | 2.05e-05 | 2 | 158 | 2 | 29788201 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 30104412 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 22318733 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 22776462 | ||
| Pubmed | Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients. | 2.05e-05 | 2 | 158 | 2 | 16959057 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 12811641 | ||
| Pubmed | The juxtaparanodal proteins CNTNAP2 and TAG1 regulate diet-induced obesity. | 2.05e-05 | 2 | 158 | 2 | 22752552 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 21030592 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 39187246 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 30478031 | ||
| Pubmed | Extrastriatal dopamine D 2/3 receptor density and distribution in drug-naive schizophrenic patients. | 2.05e-05 | 2 | 158 | 2 | 12740603 | |
| Pubmed | Molecular cloning, characterization, and genomic localization of a human potassium channel gene. | 2.05e-05 | 2 | 158 | 2 | 1349297 | |
| Cytoband | 1p36.1 | 5.08e-05 | 21 | 158 | 3 | 1p36.1 | |
| GeneFamily | Synaptotagmins | 3.84e-06 | 17 | 118 | 4 | 765 | |
| GeneFamily | Potassium voltage-gated channels | 1.31e-04 | 40 | 118 | 4 | 274 | |
| GeneFamily | Rho family GTPases | 2.85e-04 | 20 | 118 | 3 | 390 | |
| GeneFamily | Dopamine receptors | 4.17e-04 | 5 | 118 | 2 | 181 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE | 2.70e-06 | 195 | 156 | 9 | M45684 | |
| Coexpression | DESCARTES_FETAL_STOMACH_ENS_NEURONS | 5.35e-06 | 74 | 156 | 6 | M40305 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CELF5 GPRASP1 TENM2 SLC4A1 SLC39A12 STOX2 CDH22 NALCN PTPRK GPR158 NFIX RBFOX1 CNTNAP2 KCNMA1 SYT1 SYT4 KIF13A SVOP ADGRL3 RAI1 | 9.77e-06 | 1106 | 156 | 20 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | CFHR1 ABCA1 PDGFRL RHOJ ADAM9 SEMA5A RRAS ECE1 ITGB5 SLC4A1 GJA4 PTPRK MRC2 LPAR6 KCNK3 TBX2 | 2.26e-05 | 795 | 156 | 16 | M39050 |
| Coexpression | GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN | 2.66e-05 | 199 | 156 | 8 | M4673 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_DN | 2.66e-05 | 199 | 156 | 8 | M8391 | |
| Coexpression | GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN | 2.76e-05 | 200 | 156 | 8 | M3219 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | GPBAR1 CELF5 ATP13A4 DRD2 SLC39A12 KCNA5 KCNA6 TMEM145 KCNJ13 CNTNAP2 KCNK3 KCNMA1 SYT1 SYT4 SYT5 RND2 SVOP ADGRL3 CNTN2 MYBPC1 TBX2 | 3.63e-06 | 994 | 144 | 21 | PCBC_EB_1000 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CELF5 PCDHAC2 TENM2 GPR158 CNTNAP2 SYT1 SYT4 SYT5 KIF17 SVOP | 2.00e-09 | 195 | 157 | 10 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-08 | 173 | 157 | 9 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-08 | 173 | 157 | 9 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-08 | 175 | 157 | 9 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-08 | 175 | 157 | 9 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.49e-08 | 189 | 157 | 9 | b5439ef221106f6d54434f268485e9bb17b39102 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.56e-08 | 197 | 157 | 9 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.56e-08 | 197 | 157 | 9 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.56e-08 | 197 | 157 | 9 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.72e-08 | 198 | 157 | 9 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 9.97e-08 | 159 | 157 | 8 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.99e-07 | 174 | 157 | 8 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 177 | 157 | 8 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 177 | 157 | 8 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-07 | 181 | 157 | 8 | 1db1eb7d330a7e5090994007ae287e11f0a74450 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-07 | 181 | 157 | 8 | 06174ce9240c9261c0f51a1b0d875335d60722e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.18e-07 | 185 | 157 | 8 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | Multiple_Sclerosis-Other|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.45e-07 | 187 | 157 | 8 | ca6f53e841fd016804e6e8ccf0199877b0e5cbdd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.60e-07 | 188 | 157 | 8 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 3.74e-07 | 189 | 157 | 8 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-07 | 189 | 157 | 8 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.06e-07 | 191 | 157 | 8 | 2ad717b59215ad8d933e9637d363b65d7298e5d4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-07 | 193 | 157 | 8 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-07 | 193 | 157 | 8 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-07 | 193 | 157 | 8 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | 18-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 4.56e-07 | 194 | 157 | 8 | d3c90e1f1228f8ba0ba56105c6cf4f302c388f28 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 4.56e-07 | 194 | 157 | 8 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.75e-07 | 195 | 157 | 8 | 4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.75e-07 | 195 | 157 | 8 | 7a32a8535c29b819dacba901d0658280a2631c94 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.33e-07 | 198 | 157 | 8 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | Biopsy_IPF-Mesenchymal-Smooth_Muscle_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 5.53e-07 | 199 | 157 | 8 | ffb871dc3d232a7bdc2d55d91b76e79883e8fa1b | |
| ToppCell | MS-Multiple_Sclerosis-Others|Multiple_Sclerosis / Disease, condition lineage and cell class | 5.75e-07 | 200 | 157 | 8 | 3aa674db6c3e999d8175dd1e9349c18d15ec4e9b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.71e-07 | 140 | 157 | 7 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 162 | 157 | 7 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 162 | 157 | 7 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 162 | 157 | 7 | ed9ee98d6568b0ac2cd3af1d58a17364ff2cfa22 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 162 | 157 | 7 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-06 | 167 | 157 | 7 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-06 | 167 | 157 | 7 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-06 | 168 | 157 | 7 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-06 | 168 | 157 | 7 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 2.56e-06 | 171 | 157 | 7 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.09e-06 | 176 | 157 | 7 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-06 | 179 | 157 | 7 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-06 | 180 | 157 | 7 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.72e-06 | 181 | 157 | 7 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.00e-06 | 183 | 157 | 7 | 4617b18da8d699a44e4c47980197b1e7eb951470 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 183 | 157 | 7 | b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 183 | 157 | 7 | 0f02136359787bd78146617990968baa47a65d86 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 183 | 157 | 7 | 19e7be1cfdd111bfb840532a6f7c780345dffccf | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 183 | 157 | 7 | 2f0dcc65ad4d90ef946919b4462280fdd20c5ea0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.15e-06 | 184 | 157 | 7 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.15e-06 | 184 | 157 | 7 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 4.30e-06 | 185 | 157 | 7 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.45e-06 | 186 | 157 | 7 | 0c477016c1b539b3086a8066c3c6443f08c222a3 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-mesenchymal_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.53e-06 | 121 | 157 | 6 | 176de42c088988fe1a7838f96add26ee8a30e543 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.61e-06 | 187 | 157 | 7 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.61e-06 | 187 | 157 | 7 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.61e-06 | 187 | 157 | 7 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 4.61e-06 | 187 | 157 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.61e-06 | 187 | 157 | 7 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.61e-06 | 187 | 157 | 7 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 4.61e-06 | 187 | 157 | 7 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.61e-06 | 187 | 157 | 7 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-06 | 189 | 157 | 7 | 3e8e30160a8d6f531ff743cb5918c9e79481f1bd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-06 | 189 | 157 | 7 | 851f8144aed5c7f80302911cd6b03f14bde7b56d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.12e-06 | 190 | 157 | 7 | bdbfaced785db79ff965f332759be258dbf743cf | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 190 | 157 | 7 | 1c5cf933ce71fed5638b9ef31eb81f6c2b6dadbc | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.12e-06 | 190 | 157 | 7 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.12e-06 | 190 | 157 | 7 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 190 | 157 | 7 | bfbdf16d488359d7935a419c4c1823288f39c183 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 190 | 157 | 7 | eb1f8bb4d903b08e50c2dc173b06c0c79d8e316e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.12e-06 | 190 | 157 | 7 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.12e-06 | 190 | 157 | 7 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.12e-06 | 190 | 157 | 7 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.12e-06 | 190 | 157 | 7 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.12e-06 | 190 | 157 | 7 | b1095b2a7467c152d16e4f19a9515aeb61fc9e3d | |
| ToppCell | MatrixFB-Fibroblast-D_(Pericyte)|MatrixFB / shred on cell class and cell subclass (v4) | 5.49e-06 | 192 | 157 | 7 | 630444302511f511ec6976bc045a3b4b9d8d4547 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.49e-06 | 192 | 157 | 7 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.49e-06 | 192 | 157 | 7 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.49e-06 | 192 | 157 | 7 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.49e-06 | 192 | 157 | 7 | 063e119c4b58957643908f667e6cfd6f7517fd03 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.68e-06 | 193 | 157 | 7 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.68e-06 | 193 | 157 | 7 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.68e-06 | 193 | 157 | 7 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | Megakaryocytic-erythropoietic|World / Lineage, cell class and subclass | 5.68e-06 | 193 | 157 | 7 | 805c2e2e5d8a9df5ce796d5c0206d6493ab53c88 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-thrombocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.87e-06 | 194 | 157 | 7 | 7c38ead538695db1fb1c329ff67d2874aa83c8d2 | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 5.87e-06 | 194 | 157 | 7 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 5.87e-06 | 194 | 157 | 7 | b6488bc3a8905e926ad298332963e1bbaf010046 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 5.87e-06 | 194 | 157 | 7 | 1e1f4139ad584f493d75a9b7f1568eca4653c5a2 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-thrombocytic-platelet|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.87e-06 | 194 | 157 | 7 | 4531639974e363a6ff7ea688325a11407c3efd87 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.07e-06 | 195 | 157 | 7 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.07e-06 | 195 | 157 | 7 | 5a6a5048af638872700b76b7c71a8fa3fb8d3772 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.07e-06 | 195 | 157 | 7 | 1e28617ca55e5f318a228357737b968dfac8cca0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-06 | 195 | 157 | 7 | 0bdf845939bc4b8cc94f2808aea60f818425b076 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.28e-06 | 196 | 157 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-B_(Artery)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.28e-06 | 196 | 157 | 7 | f540cf17b4405a6dd38d2b6123e6541d0aac889e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.28e-06 | 196 | 157 | 7 | 8c25fa61c117a60ddd4cbd2f95ae5b66f986a1ec | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.28e-06 | 196 | 157 | 7 | 6708026bafd19c35c5c4e81911344d36a0f508cd | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-06 | 197 | 157 | 7 | 8b3bf5b45e49bf1c60e4d2703b470bb890385f67 | |
| Computational | Vesicular transport / synapse genes. | 6.93e-05 | 82 | 92 | 6 | MODULE_274 | |
| Drug | barium | RHOJ ANXA7 KCNA1 KCNA5 KCNA6 KCNA10 KCNJ13 KCNK3 KCNMA1 NOS1 | 6.85e-08 | 148 | 154 | 10 | CID000104810 |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.07e-06 | 199 | 154 | 10 | 4995_UP | |
| Drug | Pergolide | 3.44e-06 | 16 | 154 | 4 | ctd:D010479 | |
| Drug | tetrapentylammonium | 4.47e-06 | 17 | 154 | 4 | CID000017248 | |
| Drug | CID10948590 | 5.98e-06 | 6 | 154 | 3 | CID010948590 | |
| Drug | NCQ 115 | 5.98e-06 | 6 | 154 | 3 | CID000129499 | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 6.89e-06 | 193 | 154 | 9 | 3340_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; HL60; HT_HG-U133A | 7.49e-06 | 195 | 154 | 9 | 2553_UP | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 7.49e-06 | 195 | 154 | 9 | 6071_UP | |
| Drug | Nabumetone [42924-53-8]; Up 200; 17.6uM; HL60; HT_HG-U133A | 7.81e-06 | 196 | 154 | 9 | 3108_UP | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 10uM; PC3; HT_HG-U133A | 7.81e-06 | 196 | 154 | 9 | 3690_UP | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; PC3; HT_HG-U133A | 7.81e-06 | 196 | 154 | 9 | 5112_UP | |
| Drug | Vidarabine [5536-17-4]; Up 200; 15uM; HL60; HT_HG-U133A | 7.81e-06 | 196 | 154 | 9 | 2706_UP | |
| Drug | Bretylium tosylate [61-75-6]; Up 200; 9.6uM; PC3; HT_HG-U133A | 8.14e-06 | 197 | 154 | 9 | 6674_UP | |
| Drug | Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; PC3; HT_HG-U133A | 8.14e-06 | 197 | 154 | 9 | 4199_UP | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 8.47e-06 | 198 | 154 | 9 | 4230_UP | |
| Drug | Propofol [2078-54-8]; Up 200; 22.4uM; PC3; HT_HG-U133A | 8.47e-06 | 198 | 154 | 9 | 6707_UP | |
| Drug | Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 9.19e-06 | 200 | 154 | 9 | 4820_UP | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 9.19e-06 | 200 | 154 | 9 | 5969_UP | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; PC3; HT_HG-U133A | 9.19e-06 | 200 | 154 | 9 | 4447_UP | |
| Drug | APDs | 1.62e-05 | 47 | 154 | 5 | CID000016591 | |
| Drug | mephedrone | 2.47e-05 | 9 | 154 | 3 | ctd:C548233 | |
| Drug | verapamil | ABCA1 DRD2 MYO6 ACE ADCY3 KCNA1 KCNA5 KCNA6 KCNA10 KCNJ13 PKD1 KCNMA1 NOS1 | 3.01e-05 | 490 | 154 | 13 | CID000002520 |
| Drug | tetraethylammonium | 3.41e-05 | 236 | 154 | 9 | CID000005413 | |
| Drug | ergocryptine | 4.19e-05 | 29 | 154 | 4 | CID000099049 | |
| Drug | Sulpiride | 4.55e-05 | 2 | 154 | 2 | DB00391 | |
| Drug | N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride | 4.55e-05 | 2 | 154 | 2 | ctd:C016868 | |
| Drug | 5-methoxy-1-methyl-2-(n-propylamino)tetralin | 4.55e-05 | 2 | 154 | 2 | ctd:C051171 | |
| Drug | CGS 15855A | 4.55e-05 | 2 | 154 | 2 | ctd:C051347 | |
| Drug | (5,6-dimethoxyindan-2-yl)dipropylamine | 4.55e-05 | 2 | 154 | 2 | ctd:C086335 | |
| Drug | Domperidone | 4.55e-05 | 2 | 154 | 2 | DB01184 | |
| Drug | UH 232 | 4.55e-05 | 2 | 154 | 2 | ctd:C045971 | |
| Drug | 4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H-pyrzolo(3,4-g)quinoline | 4.55e-05 | 2 | 154 | 2 | ctd:C416545 | |
| Drug | 3-(3-cyanophenyl)-N-n-propylpiperidine | 4.55e-05 | 2 | 154 | 2 | ctd:C094012 | |
| Drug | iodosulpride | 4.55e-05 | 2 | 154 | 2 | ctd:C045105 | |
| Drug | fluoroclebopride | 4.55e-05 | 2 | 154 | 2 | ctd:C083673 | |
| Drug | GR 218231 | 4.55e-05 | 2 | 154 | 2 | ctd:C408390 | |
| Drug | N-(4-(2-(4-(3-cyano-5-trifluoromethylphenyl)piperazin-1-yl)ethyl)cyclohexyl)-3-pyridinesulfonic amide | 4.55e-05 | 2 | 154 | 2 | ctd:C539157 | |
| Drug | Piribedil | 4.55e-05 | 2 | 154 | 2 | ctd:D010891 | |
| Drug | AC1L31N6 | 4.55e-05 | 2 | 154 | 2 | CID000132830 | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.24e-05 | 193 | 154 | 8 | 3183_UP | |
| Drug | Cefalonium [5575-21-3]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 5.24e-05 | 193 | 154 | 8 | 7341_UP | |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; HL60; HT_HG-U133A | 5.63e-05 | 195 | 154 | 8 | 2425_UP | |
| Drug | Midecamycin [35457-80-8]; Up 200; 5uM; PC3; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 6745_UP | |
| Drug | Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; PC3; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 6747_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; PC3; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 6705_UP | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; HL60; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 3043_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 5904_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; PC3; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 4446_UP | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 7526_DN | |
| Drug | Trapidil [15421-84-8]; Up 200; 19.4uM; HL60; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 3136_UP | |
| Drug | Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 4393_UP | |
| Drug | Etomidate [33125-97-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 3519_UP | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 6036_UP | |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 6.50e-05 | 199 | 154 | 8 | 3674_UP | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; PC3; HT_HG-U133A | 6.50e-05 | 199 | 154 | 8 | 3774_UP | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 10uM; PC3; HT_HG-U133A | 6.73e-05 | 200 | 154 | 8 | 3773_UP | |
| Drug | MAMP | 1.11e-04 | 160 | 154 | 7 | CID000001206 | |
| Drug | reduced haloperidol | 1.12e-04 | 37 | 154 | 4 | CID000119265 | |
| Drug | fenoldopam | 1.13e-04 | 70 | 154 | 5 | CID000003340 | |
| Drug | AC1L2AAS | 1.30e-04 | 15 | 154 | 3 | CID000068714 | |
| Drug | K-Cl | AQP10 MYO6 ADCY3 AQP9 SLC4A1 KCNA5 KCNJ13 KCNK3 KCNMA1 AFDN MYO15A NOS1 CYB561 | 1.32e-04 | 567 | 154 | 13 | CID000004873 |
| Drug | (1-(2-(bis(4-fluorophenyl)methoxy)ethyl)-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate) | 1.36e-04 | 3 | 154 | 2 | ctd:C461261 | |
| Drug | DP-6OH-3CA | 1.36e-04 | 3 | 154 | 2 | CID000086146 | |
| Drug | 6alpha-ethyl-23(S)-methylcholic acid | 1.36e-04 | 3 | 154 | 2 | ctd:C545501 | |
| Drug | Neuriplege | 1.36e-04 | 3 | 154 | 2 | CID000065750 | |
| Drug | 7-(N,N-dipropylamino)-5,6,7,8-tetrahydronaphtho(2,3-b)dihydro-2,3-furan | 1.36e-04 | 3 | 154 | 2 | ctd:C090812 | |
| Drug | 7-hydroxy-2-N,N-dipropylaminotetralin | 1.36e-04 | 3 | 154 | 2 | ctd:C031349 | |
| Drug | Ezetimibe | 1.36e-04 | 3 | 154 | 2 | DB00973 | |
| Drug | 3-N-methylspiperone | 1.36e-04 | 3 | 154 | 2 | ctd:C039167 | |
| Drug | quinelorane | 1.36e-04 | 3 | 154 | 2 | ctd:C047726 | |
| Drug | FLA908 | 1.36e-04 | 3 | 154 | 2 | CID000129516 | |
| Drug | SB-277011 | 1.36e-04 | 3 | 154 | 2 | CID005311096 | |
| Drug | DCHAPS | 1.36e-04 | 3 | 154 | 2 | CID000129392 | |
| Drug | nafadotride | 1.36e-04 | 3 | 154 | 2 | ctd:C097285 | |
| Drug | BP 897 | 1.36e-04 | 3 | 154 | 2 | ctd:C120565 | |
| Drug | AC1L1RNO | 1.36e-04 | 3 | 154 | 2 | CID000034486 | |
| Drug | iodoethylspiperone | 1.36e-04 | 3 | 154 | 2 | CID000131222 | |
| Drug | bendrofluazide | 1.38e-04 | 39 | 154 | 4 | CID000002315 | |
| Drug | clofilium | 1.47e-04 | 74 | 154 | 5 | CID000002798 | |
| Drug | Zinc Sulfate | TBPL2 DRD2 IRF4 CDH19 ACE PKHD1L1 SIDT2 AIFM1 SYT1 SYT4 AFDN GNAS CNTN2 RAI1 TBX2 | 1.53e-04 | 739 | 154 | 15 | ctd:D019287 |
| Drug | hydrochlorothiazide | 1.68e-04 | 120 | 154 | 6 | CID000003639 | |
| Drug | AC1L1H5B | 1.77e-04 | 77 | 154 | 5 | CID000003981 | |
| Drug | isoproterenol | SCN11A DRD2 DRD3 MYO6 NCF4 ACE ADCY3 LPAR6 KCNMA1 AFDN GNAS MYO15A TUBE1 NOS1 | 1.87e-04 | 669 | 154 | 14 | CID000003779 |
| Drug | NSC 36363 | 1.92e-04 | 17 | 154 | 3 | CID000005417 | |
| Drug | N-ethylmaleimide | DRD2 MYO6 ADCY3 SLC4A1 KCNMA1 SYT1 AFDN SYT5 MYO15A FUT6 KIF13A KIF17 | 1.93e-04 | 511 | 154 | 12 | CID000004362 |
| Drug | buspirone | 2.12e-04 | 80 | 154 | 5 | CID000002477 | |
| Drug | phenothiazine | 2.21e-04 | 44 | 154 | 4 | CID000007108 | |
| Drug | 4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate) | 2.70e-04 | 4 | 154 | 2 | ctd:C110258 | |
| Drug | clofluperol | 2.70e-04 | 4 | 154 | 2 | CID000025293 | |
| Drug | Tapso | 2.70e-04 | 4 | 154 | 2 | CID000109334 | |
| Drug | Pimozide | 2.70e-04 | 4 | 154 | 2 | DB01100 | |
| Drug | NCQ-469 | 2.70e-04 | 4 | 154 | 2 | CID000127915 | |
| Drug | spectramide | 2.70e-04 | 4 | 154 | 2 | CID000130377 | |
| Drug | Amisulpride | 2.70e-04 | 4 | 154 | 2 | DB06288 | |
| Drug | sarizotan | 2.70e-04 | 4 | 154 | 2 | ctd:C443959 | |
| Drug | 3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol | 2.70e-04 | 4 | 154 | 2 | ctd:C062458 | |
| Drug | SKF83959 | 2.70e-04 | 4 | 154 | 2 | CID000133538 | |
| Drug | Dextroamphetamine | 2.71e-04 | 185 | 154 | 7 | ctd:D003913 | |
| Drug | Ro 41-9067 | 2.72e-04 | 19 | 154 | 3 | CID000125800 | |
| Disease | congenital myasthenic syndrome 7 (implicated_via_orthology) | 5.03e-07 | 4 | 149 | 3 | DOID:0110659 (implicated_via_orthology) | |
| Disease | neuromuscular junction disease (implicated_via_orthology) | 1.25e-06 | 5 | 149 | 3 | DOID:439 (implicated_via_orthology) | |
| Disease | Pulmonary Hypertension | 1.75e-06 | 40 | 149 | 5 | C0020542 | |
| Disease | epilepsy (implicated_via_orthology) | 2.01e-05 | 163 | 149 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 6.73e-05 | 16 | 149 | 3 | DOID:3635 (implicated_via_orthology) | |
| Disease | Disruptive, Impulse Control, and Conduct Disorders | 7.57e-05 | 3 | 149 | 2 | C0021122 | |
| Disease | Costello syndrome (implicated_via_orthology) | 7.57e-05 | 3 | 149 | 2 | DOID:0050469 (implicated_via_orthology) | |
| Disease | Intermittent Explosive Disorder | 7.57e-05 | 3 | 149 | 2 | C0021776 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 1.15e-04 | 19 | 149 | 3 | DOID:1591 (biomarker_via_orthology) | |
| Disease | neuroticism measurement, cognitive function measurement | 1.50e-04 | 566 | 149 | 11 | EFO_0007660, EFO_0008354 | |
| Disease | Generalized seizures | 1.65e-04 | 101 | 149 | 5 | C0234533 | |
| Disease | Clonic Seizures | 1.65e-04 | 101 | 149 | 5 | C0234535 | |
| Disease | Convulsive Seizures | 1.65e-04 | 101 | 149 | 5 | C0751494 | |
| Disease | Seizures, Sensory | 1.65e-04 | 101 | 149 | 5 | C0751496 | |
| Disease | Non-epileptic convulsion | 1.65e-04 | 101 | 149 | 5 | C0751056 | |
| Disease | Atonic Absence Seizures | 1.65e-04 | 101 | 149 | 5 | C0751123 | |
| Disease | Complex partial seizures | 1.65e-04 | 101 | 149 | 5 | C0149958 | |
| Disease | Single Seizure | 1.65e-04 | 101 | 149 | 5 | C0751110 | |
| Disease | Nonepileptic Seizures | 1.65e-04 | 101 | 149 | 5 | C3495874 | |
| Disease | Visual seizure | 1.65e-04 | 101 | 149 | 5 | C0270824 | |
| Disease | Epileptic drop attack | 1.65e-04 | 101 | 149 | 5 | C0270846 | |
| Disease | Vertiginous seizure | 1.65e-04 | 101 | 149 | 5 | C0422855 | |
| Disease | Gustatory seizure | 1.65e-04 | 101 | 149 | 5 | C0422854 | |
| Disease | Seizures, Somatosensory | 1.65e-04 | 101 | 149 | 5 | C0422850 | |
| Disease | Olfactory seizure | 1.65e-04 | 101 | 149 | 5 | C0422853 | |
| Disease | Seizures, Auditory | 1.65e-04 | 101 | 149 | 5 | C0422852 | |
| Disease | Generalized Absence Seizures | 1.65e-04 | 101 | 149 | 5 | C4505436 | |
| Disease | Jacksonian Seizure | 1.65e-04 | 101 | 149 | 5 | C0022333 | |
| Disease | Epileptic Seizures | 1.65e-04 | 101 | 149 | 5 | C4317109 | |
| Disease | Absence Seizures | 1.72e-04 | 102 | 149 | 5 | C4316903 | |
| Disease | Convulsions | 1.72e-04 | 102 | 149 | 5 | C4048158 | |
| Disease | Tonic Seizures | 1.72e-04 | 102 | 149 | 5 | C0270844 | |
| Disease | Attention Deficit Disorder | 1.81e-04 | 22 | 149 | 3 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 1.81e-04 | 22 | 149 | 3 | C1321905 | |
| Disease | Seizures, Focal | 1.89e-04 | 104 | 149 | 5 | C0751495 | |
| Disease | Myoclonic Seizures | 1.89e-04 | 104 | 149 | 5 | C4317123 | |
| Disease | Tonic - clonic seizures | 1.89e-04 | 104 | 149 | 5 | C0494475 | |
| Disease | Attention deficit hyperactivity disorder | 2.36e-04 | 24 | 149 | 3 | C1263846 | |
| Disease | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | 2.44e-04 | 60 | 149 | 4 | EFO_0001365, EFO_0004683, EFO_1001492 | |
| Disease | lung carcinoma (is_marker_for) | 2.51e-04 | 5 | 149 | 2 | DOID:3905 (is_marker_for) | |
| Disease | fecal incontinence | 2.51e-04 | 5 | 149 | 2 | EFO_0009523 | |
| Disease | heroin dependence (biomarker_via_orthology) | 2.51e-04 | 5 | 149 | 2 | DOID:9976 (biomarker_via_orthology) | |
| Disease | PCSK9 protein measurement | 3.01e-04 | 26 | 149 | 3 | EFO_0006899 | |
| Disease | Alzheimer's disease (is_marker_for) | 3.44e-04 | 257 | 149 | 7 | DOID:10652 (is_marker_for) | |
| Disease | spine bone mineral density | 3.53e-04 | 119 | 149 | 5 | EFO_0007701 | |
| Disease | Digitotalar Dysmorphism | 3.75e-04 | 6 | 149 | 2 | C1852085 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 1 | 3.75e-04 | 6 | 149 | 2 | C0220662 | |
| Disease | Autistic Disorder | 3.77e-04 | 261 | 149 | 7 | C0004352 | |
| Disease | hypertension (is_implicated_in) | 3.81e-04 | 121 | 149 | 5 | DOID:10763 (is_implicated_in) | |
| Disease | chloride measurement | 4.19e-04 | 29 | 149 | 3 | EFO_0009284 | |
| Disease | response to angiotensin receptor blocker | 4.64e-04 | 30 | 149 | 3 | EFO_0010735 | |
| Disease | hypertension (implicated_via_orthology) | 4.93e-04 | 128 | 149 | 5 | DOID:10763 (implicated_via_orthology) | |
| Disease | DNA methylation | DCHS2 ABCA1 DRD2 SLC2A9 TMEM135 CDH19 F13A1 CNTNAP2 KCNMA1 USH2A DNAH6 | 5.23e-04 | 656 | 149 | 11 | GO_0006306 |
| Disease | Obesity, Morbid | 5.23e-04 | 7 | 149 | 2 | C0028756 | |
| Disease | cortical thickness | GPBAR1 CELF5 CHSY1 ECE1 TENM2 ITGB5 KCNA5 NFIX PKD1 KCNK3 DOCK7 SYT1 KIF13A ARHGAP21 SOAT1 | 5.32e-04 | 1113 | 149 | 15 | EFO_0004840 |
| Disease | Schizophrenia | ABCA1 DRD2 DRD3 PTPN21 ACE CLU TPH2 CNTNAP2 GNAS CDC42 KIF17 NOS1 RAI1 | 5.62e-04 | 883 | 149 | 13 | C0036341 |
| Disease | response to allopurinol, uric acid measurement | 5.62e-04 | 32 | 149 | 3 | EFO_0004761, EFO_0006337 | |
| Disease | Hyperkinesia | 5.62e-04 | 32 | 149 | 3 | C3887506 | |
| Disease | Hyperkinesia, Generalized | 5.62e-04 | 32 | 149 | 3 | C0751217 | |
| Disease | white matter volume measurement | 5.62e-04 | 32 | 149 | 3 | EFO_0008320 | |
| Disease | Hypoxemia | 6.16e-04 | 33 | 149 | 3 | C0700292 | |
| Disease | Hypoxia | 6.16e-04 | 33 | 149 | 3 | C0242184 | |
| Disease | Anoxemia | 6.16e-04 | 33 | 149 | 3 | C0003129 | |
| Disease | Anoxia | 6.16e-04 | 33 | 149 | 3 | C0003130 | |
| Disease | diabetic retinopathy | 6.50e-04 | 136 | 149 | 5 | EFO_0003770 | |
| Disease | pantothenate measurement | 6.95e-04 | 8 | 149 | 2 | EFO_0021034 | |
| Disease | Alzheimer disease | ABCA1 HS3ST5 TENM2 CLU RBFOX1 CNTNAP2 CATSPERB MYO15A CYB561 | 8.34e-04 | 485 | 149 | 9 | MONDO_0004975 |
| Disease | short-term memory | 8.42e-04 | 83 | 149 | 4 | EFO_0004335 | |
| Disease | eye colour measurement | 8.67e-04 | 218 | 149 | 6 | EFO_0009764 | |
| Disease | Distal arthrogryposis | 8.91e-04 | 9 | 149 | 2 | cv:C0265213 | |
| Disease | Idiopathic pulmonary hypertension | 8.91e-04 | 9 | 149 | 2 | C0152171 | |
| Disease | RASopathy (implicated_via_orthology) | 8.91e-04 | 9 | 149 | 2 | DOID:0080690 (implicated_via_orthology) | |
| Disease | Recurrent depression | 8.91e-04 | 9 | 149 | 2 | C0221480 | |
| Disease | Pituitary Adenoma | 8.91e-04 | 9 | 149 | 2 | C0032000 | |
| Disease | urinary bladder cancer (implicated_via_orthology) | 8.91e-04 | 9 | 149 | 2 | DOID:11054 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 9.21e-04 | 85 | 149 | 4 | C1510586 | |
| Disease | dilated cardiomyopathy (is_marker_for) | 1.01e-03 | 39 | 149 | 3 | DOID:12930 (is_marker_for) | |
| Disease | Delirium | 1.11e-03 | 10 | 149 | 2 | C0011206 | |
| Disease | glaucoma | 1.14e-03 | 154 | 149 | 5 | MONDO_0005041 | |
| Disease | ceramide measurement | 1.28e-03 | 235 | 149 | 6 | EFO_0010222 | |
| Disease | Adrenal Gland Neoplasms | 1.35e-03 | 11 | 149 | 2 | C0001624 | |
| Disease | Adrenal Cancer | 1.35e-03 | 11 | 149 | 2 | C0750887 | |
| Disease | eye disease | 1.53e-03 | 45 | 149 | 3 | EFO_0003966 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.58e-03 | 166 | 149 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | Lenticulostriate Disorders | 1.62e-03 | 12 | 149 | 2 | C0750951 | |
| Disease | Extrapyramidal Disorders | 1.62e-03 | 12 | 149 | 2 | C0015371 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.62e-03 | 12 | 149 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | temporal pole volume measurement | 1.62e-03 | 12 | 149 | 2 | EFO_0010334 | |
| Disease | Basal Ganglia Diseases | 1.62e-03 | 12 | 149 | 2 | C0004782 | |
| Disease | Neurobehavioral Manifestations | 1.62e-03 | 12 | 149 | 2 | C0525041 | |
| Disease | myocardial infarction (is_implicated_in) | 1.62e-03 | 99 | 149 | 4 | DOID:5844 (is_implicated_in) | |
| Disease | Endogenous depression | 1.63e-03 | 46 | 149 | 3 | C0011573 | |
| Disease | melanoma | 1.68e-03 | 248 | 149 | 6 | C0025202 | |
| Disease | coronary artery disease (is_implicated_in) | 1.68e-03 | 100 | 149 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | triglyceride measurement, alcohol consumption measurement | 1.74e-03 | 101 | 149 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | pancreatic cancer (is_marker_for) | 1.74e-03 | 101 | 149 | 4 | DOID:1793 (is_marker_for) | |
| Disease | ghrelin measurement | 1.96e-03 | 49 | 149 | 3 | EFO_0600001 | |
| Disease | Unipolar Depression | 2.08e-03 | 259 | 149 | 6 | C0041696 | |
| Disease | mental or behavioural disorder | 2.20e-03 | 179 | 149 | 5 | EFO_0000677 | |
| Disease | Ciliopathies | 2.38e-03 | 110 | 149 | 4 | C4277690 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IPESGDYFIYSQVTF | 141 | O95150 | |
| IPTQTYTREYFTFPA | 1221 | P55196 | |
| ENATAHIFATYPAPY | 141 | O43315 | |
| APIQYYSVEFIRPDF | 171 | Q63HQ2 | |
| FFAYVPENEPQETIY | 551 | Q9H7T0 | |
| VFYAPQTYAAIPSLH | 346 | Q9NQ94 | |
| VPNVTPYIRYFVSFV | 521 | P12821 | |
| PYYLSDITDAFSPQV | 391 | P02730 | |
| IAFADYTVTYQEQPP | 986 | Q8N7X0 | |
| EPSAFNDFQRPAIYY | 391 | O14977 | |
| RSIYFQPPSFYVSAQ | 201 | O95831 | |
| PFRQPTYTNYIFVLV | 1061 | Q4VNC1 | |
| PYSDPSVVFVFLSVF | 711 | O95477 | |
| SLVDVPFPNSYQYIA | 351 | Q9HAR2 | |
| YAFSPVISDFYSSLP | 166 | A6NJG6 | |
| ETASIFATYPAPYLS | 141 | Q96PS8 | |
| VNPSSIQKPTYSLYF | 1446 | Q8IYW2 | |
| EYPVQIEPDTFYTAS | 456 | Q9Y2F9 | |
| FSSYPVFSPVSLDYS | 151 | P20073 | |
| TQPTAFEFVRPYSDY | 676 | O60563 | |
| AAATPTALPYYVAFS | 6 | P49447 | |
| FSRYFQYEGSLTTPP | 321 | Q16790 | |
| AAVRTPEQYYQTFSP | 326 | Q7Z5J4 | |
| LPAYFAKSATIYNPV | 306 | P04000 | |
| IIFPESDYQIFSYPN | 4366 | Q99102 | |
| FYTFVSPVLNPLIYS | 276 | Q96RB7 | |
| VVYSVLTPFLNPFIY | 276 | Q8NGY5 | |
| PNFSLADLESPSYYN | 241 | Q14938 | |
| ALPVPVIVSNFNYFY | 401 | Q09470 | |
| DFFTVPPVFVSVYLN | 251 | Q12791 | |
| FLEDYFTSAEPQYQP | 511 | P09769 | |
| TYDASNLDQVLFPYP | 281 | Q15306 | |
| STKLPFDLSIYFPYV | 181 | Q5VWC8 | |
| EVPYFYPEESASAFV | 396 | Q9UKN7 | |
| SSQAIFPAPYLYLEV | 156 | Q8TDU6 | |
| YFPVVILYFEPSTFR | 466 | Q5T848 | |
| TQPQYVAFSFVYILT | 216 | O14649 | |
| SYPQQITIEKSPAYF | 146 | Q8IZT8 | |
| VFDFATLNPTPFSYE | 1361 | O43157 | |
| FSEQYTPEADPYFIQ | 1596 | Q14766 | |
| DNPPTFSQVSYFTYI | 451 | Q9Y5H3 | |
| YLPPTLEFAVYTFNK | 46 | Q5W188 | |
| RHPPTFDNLYEYFIS | 2926 | Q96JB1 | |
| TFNYTLYPITFPSEN | 171 | Q4G148 | |
| FPSSTSPYEYVQEQR | 2831 | Q86YZ3 | |
| FFIFPLTYYHSITPS | 236 | O60928 | |
| IFFYQSPYDSEQVPQ | 131 | Q15080 | |
| DIFNTSIVTPIYYVF | 241 | Q8N8Q9 | |
| AYVPDPYTQAFLTQA | 1161 | Q9UBG0 | |
| QSFYVQIDFSRPYDP | 81 | P00488 | |
| TPGHTRYFQTYFLTP | 391 | P36915 | |
| FDPIVYYFTSDTIQN | 286 | P43657 | |
| ISYTTNKFPSEYVPT | 21 | P60953 | |
| NKFPSEYVPTVFDNY | 26 | P60953 | |
| AFYTIFTPVLNPLIY | 281 | Q8NGX1 | |
| AFYTIFTPVLNPLIY | 281 | Q8NH03 | |
| DISPFSYTAPRYQTN | 186 | P18084 | |
| YANDAFPEEYVPTVF | 41 | Q9H4E5 | |
| VYFTFQFYRFPPATT | 666 | O75161 | |
| FQAFKYYLDITTPPT | 1096 | P29475 | |
| FYSIITPTLNPFTYT | 281 | Q5JQS5 | |
| YTEPYASSQDNLFVP | 351 | Q16825 | |
| PSFPTLYYQSSVRED | 1931 | Q6V1P9 | |
| YVYARPFTALPTDTA | 256 | Q8NGE8 | |
| PPSFLEDSYSIYIQE | 466 | Q9Y5I4 | |
| YATEFPEQSYLAIPA | 936 | Q9UHC9 | |
| LPVPVIVSNFNYFYH | 451 | Q16322 | |
| PDSYFDAFTSPYINN | 556 | Q9C0G6 | |
| SYYFVPEPSDLQSAV | 186 | Q9NSI5 | |
| PVPVIVSNFNYFYHR | 511 | P22460 | |
| ALPVPVIVSNFNYFY | 451 | P17658 | |
| LEFPARDVYVPNTTY | 546 | Q96N67 | |
| FPTTYYQNATDVPRT | 261 | I3L273 | |
| FPVEDVFTLPVYFSS | 191 | Q9H9V9 | |
| SLTLPFSPYSAYAQA | 236 | Q8N6W0 | |
| YHSPQEDPFLFTYAS | 381 | Q9NP62 | |
| YFPEFARYTTPEDAT | 311 | P63092 | |
| TFVPESLENLYQTYF | 56 | O60266 | |
| VPIYANRFAVPTYAA | 766 | Q13443 | |
| FVYSNESVRPYTPFE | 771 | Q02246 | |
| FSYLRVSQDDPTVYP | 31 | P51993 | |
| PPTFEDTAVAYYQQA | 86 | Q9HAW0 | |
| FSAINPVLYYYPFVT | 171 | Q3C1V0 | |
| FYAPQAISKVQPSSY | 376 | Q8N6P7 | |
| SVVNAPTPYIKAFYN | 76 | Q9NRM0 | |
| PYTVPVFFNATSYLE | 371 | Q9UHC6 | |
| DLSVPPYDAFQTYAF | 761 | Q9UJ99 | |
| SDPYTDQVFFYLPVG | 256 | P35212 | |
| NPAFVVYSSIVSFYV | 186 | P14416 | |
| NAYYSPTKNEIVFPA | 566 | P42892 | |
| FFTAYGPDYVLEITP | 336 | Q9BY41 | |
| SFPLSVYAPASSVEY | 221 | Q03591 | |
| YFSVPPFAYEDIARN | 141 | O95479 | |
| AAFTISYVYSAELFP | 431 | Q9Y226 | |
| NLPSPDYFTEYIFSS | 226 | Q504Y0 | |
| YSSLFVIYEIPPSDA | 756 | Q9Y2W3 | |
| LLPYYVFEVFEETPQ | 371 | Q9H159 | |
| SQYFYEAPIFTIPGR | 726 | Q14562 | |
| PDFVIYSSVVSFYLP | 186 | P35462 | |
| SNPFPFGYISNYTVS | 2831 | P98161 | |
| DSYRQPAAFIVTQYP | 1236 | Q15262 | |
| AAFYTYVLPQSFHTP | 251 | Q8NH01 | |
| ASSAEYPPAFQYETV | 481 | Q9P2E2 | |
| SQPYVPVEFADFSVY | 1546 | Q9H1H9 | |
| ASSGNYYFIPYIVTP | 176 | Q6ZN16 | |
| FPFQYDPSYRSVQEI | 1111 | Q5JY77 | |
| YIFPTYGVTPNHSAF | 261 | Q6NUM9 | |
| LNPYYNESFSFEVPF | 336 | P21579 | |
| ETFTFYGIPYTQIQE | 221 | Q9H2B2 | |
| TLNPYYNEAFSFEVP | 301 | O00445 | |
| PYFNEAFTFLVPFSQ | 306 | Q8NBV8 | |
| LYPFSFDPVTFNYTD | 4306 | O75445 | |
| YRYAQPTPATAAAYS | 316 | Q9NWB1 | |
| IPFSTFQFLYTYIAE | 156 | Q9BZX4 | |
| FQAAYVYTPEVYPTA | 441 | Q8N4V2 | |
| IPTVNQYLYFLFAPT | 291 | P35610 | |
| TTAAQPQYFKYEFPE | 166 | Q8NBJ9 | |
| VVFSLLLSYFPSPYQ | 241 | Q1RMZ1 | |
| PIGLTYQFSEPYFLA | 1421 | Q5K651 | |
| KVEAYSPYQFESPQT | 71 | Q9Y581 | |
| ESSFPQYLDVLAPYV | 381 | Q8NA58 | |
| TFPSDITEFLGQPYF | 221 | Q6NW34 | |
| HPAYPSIFTRVTYFI | 301 | A8MTI9 | |
| TIQFIQSYFVTDYDP | 31 | P62070 | |
| LFDYIQAVTSYLAPP | 456 | Q2M3M2 | |
| TDPAPVADYLTSQFY | 586 | Q9Y4R8 | |
| IYNPPESNASVIFDY | 1986 | Q9NT68 | |
| FTVVFQPFFYETTPS | 276 | Q6P1J6 | |
| GELFVPSPSYFDVVY | 171 | Q15198 | |
| TFSTSPQDFPFYYLQ | 396 | Q92935 | |
| PGEVPFYYNELQSTF | 281 | Q13591 | |
| FPIIFSQYDPKIVYS | 656 | Q86X52 | |
| FTREPQDTYHYLPFS | 196 | P10909 | |
| YYKSQTRFAPFLPES | 151 | Q8NBR9 | |
| YVPTVFENYTASFEI | 36 | P52198 | |
| EGYARYSVSVFQPPF | 861 | O94966 | |
| PYSTFRTYVFPETDF | 246 | Q13207 | |
| EFPEVYRFVTSIYPS | 166 | Q9UJT0 | |
| YFIVTPQTYFITPSL | 136 | Q9P2F5 | |
| DKVFYAPVPTVTAYS | 121 | Q6ZTI6 | |
| VPYFPHADTIIYSIS | 371 | Q86UB9 | |
| LYSQLVYSTPTPFFH | 101 | P42768 | |
| TIHFTSEYNYAPPVV | 56 | Q5VVX9 | |
| IFVNTIAYPPLLFTY | 1896 | Q86WI1 | |
| YFTTPIFYVNAAPHI | 46 | Q96GW9 | |
| YTSAIEVQPNFEVPY | 81 | Q5I0X7 | |
| AKSITRPFSVYFNPY | 436 | Q8IWU9 | |
| RPFSVYFNPYTQSIE | 441 | Q8IWU9 | |
| DYDNVPTTVFTPLEY | 391 | Q9NNW7 | |
| PEFESNSLGYIYFVV | 1276 | Q9UI33 | |
| IPFVYSLSFSPGYTF | 166 | P16662 | |
| TIQFIQSYFVSDYDP | 46 | P10301 | |
| ESVFPLSHLQYFYPE | 1846 | Q14669 | |
| HFIVYPPESAIQFSY | 66 | Q5T5U3 | |
| YFLSQYVSPADSPFR | 716 | Q9UP52 | |
| QFSSYEPELFPGLIY | 316 | Q6SJ96 | |
| FFDPGQVLYTYESPA | 301 | Q8NBT3 | |
| VYTNYPFPGETFNRE | 46 | P35573 | |
| FEHYPPLQYVTFTLD | 61 | Q8IZF0 | |
| AVNPYFDIPKIYSSE | 96 | Q9UM54 | |
| YVFAPDAYNVTLPAK | 501 | Q00872 |